{"id":5579,"date":"2015-05-09T14:15:59","date_gmt":"2015-05-09T14:15:59","guid":{"rendered":"\/?p=5579"},"modified":"2015-05-09T14:34:26","modified_gmt":"2015-05-09T14:34:26","slug":"pharmacyte-biotech-inc-otcmktspmcbs-recovery-didnt-last","status":"publish","type":"post","link":"\/articles\/pharmacyte-biotech-inc-otcmktspmcbs-recovery-didnt-last\/","title":{"rendered":"PharmaCyte Biotech, Inc. (OTCMKTS:PMCB)&#8217;s Recovery Didn&#8217;t Last"},"content":{"rendered":"\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/90\/90038\/fsafas.png\" border=\"0\" width=\"429\" height=\"191\" \/>PharmaCyte Biotech, Inc. (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a>) had a nice little bounce on Wednesday, but yesterday&#8217;s trading session nearly wiped all of its gains, in spite of the investors&#8217; relative inactivity. <\/p>\n<p>This state of developments is not exactly unexpected for investors that have kept a close eye on <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a> <\/strong>in these last few months.<\/p>\n<p>The company claims to be making progress, and with regard to its scientific research it may well be &ndash; and that is certainly working to its advantage. The Cell-in-a-Box is an interesting technology that has online analysts ecstatic over its potential for helping insulin-dependent diabetes patients live without daily insulin injections.<\/p>\n<p>Unfortunately, the company represents more than just boundless opportunity. Due diligence on it reveals that it is a risky investment, as it is far from financially sound:<\/p>\n<ul>\n<li>Cash &#8211; 958 thousand<\/li>\n<li>Total liabilities &#8211; $378 thousand<\/li>\n<li>NO REVENUES<\/li>\n<li>Quarterly net loss &#8211; $1.45 million<\/li>\n<\/ul>\n<p>Those numbers are bad enough, but it is probably the constant barrage of paid pumps that has eroded investor confidence in <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a> <\/strong>over the last few months the most. Unfortunately for opportunistic traders, prolonged paid pumps have a tendency to lose their potency.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: left;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/90\/90038\/fssa.png\" border=\"0\" width=\"110\" height=\"110\" \/>After more than 100 t\u043euts in 2015 alone, this seems to be what has happened to <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a><\/strong>. Now it seems that even Microcap Daily&#8217;s ridiculously optimistic commentary seems in capable of changing that state of developments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) had a nice little bounce on Wednesday, but yesterday&#8217;s trading session nearly wiped all of its gains, in spite of the investors&#8217; relative inactivity. This state of developments is not&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1635],"class_list":["post-5579","post","type-post","status-publish","format-standard","hentry","category-news","tag-pmcb"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/5579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=5579"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/5579\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=5579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=5579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=5579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}